Skip to content

Thyroid Profiles in Patients With Acute Illness

Thyroid Profiles in Middle Eastern Patients Admitted With Acute Illness: Prevalence, Clinical Features and Impact on Mortality

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05980923
Enrollment
0
Registered
2023-08-08
Start date
2023-10-15
Completion date
2025-01-30
Last updated
2025-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Illness, Thyroid Dysfunction

Keywords

Thyroid abnormalities, Acute illness, Prognosis, Middle east

Brief summary

Patients admitted to the hospital with acute illness may have a wide spectrum of thyroid function abnormalities. It is largely unknown whether such aberrations are temporary or persist for a long time, and whether they impact prognosis of such patients.

Detailed description

Recently, there has been a growing body of evidence that subclinical thyroid dysfunction as a contributor to the increase of cardiovascular events. Elevated serum thyroid-stimulating hormone (TSH) levels and normal free thyroxine (FT4) and free triiodothyronine (FT3) levels have been associated with worse heart failure and dyslipidemia. Furthermore, higher risk of atrial fibrillation has been linked tp thyroid abnormalities in these patients. Patients admitted to the hospital with acute illness may have a wide spectrum of thyroid function abnormalities. It is largely unknown whether such aberrations are temporary or persist for a long time, and whether they impact prognosis of such patients. This study aimed at evaluating the prevalence of thyroid function abnormalities in patients admitted to hospital with acute illness and their temporal changes and impact on mortality during hospitalization and at 1 year. Serum level of thyroid stimulating hormone and free T4 and T3 measured on admission. Clinical and laboratory profiles of patients with abnormal thyroid function (ATF group) will be compared to those with normal thyroid function (NTF group). Short and long term survival of both groups were compares as well.

Interventions

OTHERPerforming blood thyroid test (TSH, FT4, FT3)

Blood test as above

Sponsors

Jordan Collaborating Cardiology Group
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Hospital admission * Adults aged 18 years and above * Willing to sign an informed consent * Diagnosis on admission is acute illness that includes: heart failure, acute coronary syndrome, sepsis, acute stroke, hypotension, acute system-organ failure including renal and hepatic failure.

Exclusion criteria

* Age less than 18 years. * Refusal to sign consent. * Admission for a reason not classified as acute illness.

Design outcomes

Primary

MeasureTime frameDescription
In hospital mortalityFrom time of study entry until the date of death from any cause, assessed up to 2 weeks.All-cause death rate in patients with abnormal thyroid function compared with death in those with no abnormal thyroid function during the patients hospital stay..

Secondary

MeasureTime frameDescription
6-month mortality rateFrom date of study entry until the date of death from any cause, assessed up to two weeks.All-cause death rate in patients with abnormal thyroid function compared with death in those with no abnormal thyroid function at 6 months.

Countries

Jordan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026